# Nebulized Bupivacaine Analgesia for Cleft Palate Repair

> **NCT04928352** · PHASE3 · RECRUITING · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Cleft Palate

## Interventions

- **DRUG:** Bupivacaine Hydrochloride
- **OTHER:** 0.9% saline

## Key facts

- **NCT ID:** NCT04928352
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-14
- **Primary completion:** 2026-08-10
- **Final completion:** 2026-09-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04928352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04928352, "Nebulized Bupivacaine Analgesia for Cleft Palate Repair". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04928352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*